Serum 25-hydroxyvitamin D (25OHD) tests in France have surged by tenfold over the past decade, often for questionable reasons.
In 2013, the French National Authority for Health imposed limits on when these tests could be ordered, restricting them mainly to specific health conditions like rickets and certain cases in older adults.
The authors argue that there are additional valid reasons for testing, supported by research, and advocate for the continued reimbursement of serum 25OHD tests for broader clinical scenarios.